Hospital-Anchored real estate wins as RMR Group closes $272 million Cedars-Sinai refinancing. The $272.1 million mortgage, priced at Term SOFR plus 180 basis points, retires debt maturing in early 2027 and illustrates why on-campus medical office properties keep drawing lenders that have retreated from conventional commercial real estate. By Sabastian Niles / Published: Oct 14 2026, 11:40 AM EDT The RMR Group has secured $272.1 million in financing for two medical office towers on the Cedars-Sinai Medical Center campus in Los Angeles - a deal that cuts through the ongoing debate about where lenders are willing to put commercial real estate money to work. Announced Monday by Newton, Massachusetts-based RMR, the interest-only mortgage is secured by the twin 11-story buildings at 8631 and 8635 West Third Street, which together span roughly 330,000 square feet and are physically connected to Cedars-Sinai Medical Center by an overhead walkway. Two structured parking garages are also part of the collateral package. Cedars-Sinai and its affiliates occupy approximately 60% of the total rentable space, making the health system both the portfolio's economic anchor and its clearest credit argument. The remaining tenancy draws largely from the broader medical ecosystem the campus generates - specialty practices, outpatient services, and clinical operations that depend on proximity to one of the country's most recognized hospital systems. The new loan carries an interest rate of one-month Term SOFR plus 180 basis points, with an initial two-year term and three one-year extension options that could carry the financing as far as five years. Its primary purpose was to retire roughly $267 million of existing mortgage debt scheduled to come due in February 2027. Getting ahead of that maturity rather than navigating a refinancing amid potential market volatility was itself part of the calculus. "This refinancing reflects the quality of this medical office portfolio, which is located on the campus of one of the nation's leading healthcare institutions," said Adam Portnoy, president and chief executive officer of RMR Group (Nasdaq: RMR), which manages more than $37 billion in assets. "By refinancing its upcoming maturity with a new loan that provides term extension flexibility, the joint venture is well positioned to continue benefiting from the portfolio's strong anchor tenancy, strategic location and attractive long-term fundamentals." The joint venture behind the properties is primarily held by private institutional investors. Diversified Healthcare Trust (Nasdaq: DHC), a separate RMR-managed REIT focused on healthcare properties, holds a 20% equity interest. DHC's portfolio spans roughly 7.4 million square feet of life science and medical office properties and more than 26,000 senior living units across 34 states and Washington, D.C. The deal lands at a moment when the medical office building sector has regained considerable investor and lender confidence after a period of tighter credit conditions and rising rates. MOB investment volume reached $6.7 billion in the first half of 2026, a 21% increase from the same period a year earlier, according to a mid-year update from Cushman & Wakefield. Portfolio transactions more than doubled, surpassing $2.6 billion, and cap rates compressed 35 basis points year over year to approximately 6.8%. "Cap rate compression, renewed debt market liquidity, and rising portfolio demand all point to improving investor confidence, while steady rent growth and high occupancy levels reinforce the sector's underlying fundamentals," said Sandy Romero, head of office and alternatives research at Cushman & Wakefield. "With capital becoming more readily available, we expect MOBs to remain well-positioned to attract institutional investment through the balance of 2026." That recovery is not uniform across healthcare real estate. Suburban single-tenant clinics, standalone urgent-care buildings, and properties with short lease terms have faced considerably more friction in the debt market. What lenders are gravitating toward is a narrower profile: hospital-adjacent or on-campus buildings with long-lease anchor tenants in supply-constrained markets. The Cedars-Sinai portfolio fits all three criteria in a Los Angeles market that has already posted some of the strongest rent growth figures in the country for medical outpatient space. Nationally, MOB rents rose roughly 6.2% over the past two years even as conventional office rents fell across most major metros, according to industry data. The $272.1 million financing illustrates something specific about how hospital-anchored medical office competes for debt capital. The assets borrow credibility from the anchor institution - a skybridge to Cedars-Sinai is not merely a physical convenience, it's a lease retention mechanism and a demand generator. Specialists want to be a corridor away from the operating rooms that send them referrals, and that structural dynamic makes lenders more comfortable writing checks that traditional office deals can no longer reliably obtain. RMR's decision to refinance ahead of the February 2027 maturity also reflects a broader pattern among sophisticated borrowers in 2026: execute when markets are open rather than waiting for optimal timing that may not materialize. Commercial property debt maturities are heavily back-loaded in the current cycle, and refinancing windows that look manageable now can narrow quickly if Treasury yields shift or a property's occupancy profile changes. For REIT investors tracking DHC, the Cedars-Sinai deal is incremental but directionally positive. The REIT's 20% stake means the refinancing extends debt flexibility at the asset level while keeping credit obligations structurally separated from DHC's own balance sheet - a distinction worth noting for shareholders monitoring the trust's overall leverage position. The Cedars-Sinai deal is a data point about lender appetite for a specific, defensible product type: long-leased, hospital-affiliated, supply-constrained, and institutional-quality. It is not evidence that CRE credit markets have reopened broadly. Conventional office, certain retail formats, and assets with near-term lease rollover risk continue to face genuine headwinds, and borrowers in those categories should not read this deal as a comparable template. DHC is expected to report third-quarter 2026 results in the coming weeks, which will offer updated guidance on portfolio performance and any further financing activity across its managed assets. For the medical office sector overall, Cushman & Wakefield and other researchers will release full second-half data in early 2027 that will test whether the momentum evident in the mid-year survey carried through. Join the Discussion EDITOR'S PICKS

The RMR Group Inc. (NASDAQ:RMR) stock rated "Moderate Buy" by Wall Street brokerages. October 9, 2026 Key points. * Analyst sentiment is moderately positive: Five brokerages rate The RMR Group a consensus "Moderate Buy," with three buys and two holds. The average 12-month price target is $21.33, including Maxim Group's new $26.00 target. * Quarterly results were mixed: RMR reported $0.15 in earnings per share, slightly below the $0.16 consensus, while revenue of $153.51 million exceeded estimates of $147.60 million. * The stock offers a high dividend yield: RMR declared a quarterly dividend of $0.45 per share, equivalent to $1.80 annually and a 10.2% yield. However, its 157.89% payout ratio exceeds reported earnings. * MarketBeat previews the top five stocks to own by November 1st. Shares of The RMR Group Inc. (NASDAQ:RMR - Get Free Report) have received an average recommendation of "Moderate Buy" from the five brokerages that are currently covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $21.33. Several brokerages have recently weighed in on RMR. Maxim Group began coverage on shares of The RMR Group in a research report on Friday. They issued a "buy" rating and a $26.00 price target for the company. Weiss Ratings lowered shares of The RMR Group from a "hold (c+)" rating to a "hold (c)" rating in a report on Tuesday, September 1st. The RMR Group stock performance. Shares of NASDAQ RMR opened at $17.71 on Friday. The stock has a market cap of $568.14 million, a PE ratio of 15.54 and a beta of 1.00. The company has a debt-to-equity ratio of 0.06, a current ratio of 0.24 and a quick ratio of 0.24. The firm has a fifty day moving average price of $19.10 and a 200-day moving average price of $19.02. The RMR Group has a 1 year low of $14.27 and a 1 year high of $21.45. The RMR Group (NASDAQ:RMR - Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The financial services provider reported $0.15 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.16 by ($0.01). The RMR Group had a net margin of 3.10% and a return on equity of 2.96%. The company had revenue of $153.51 million during the quarter, compared to the consensus estimate of $147.60 million. Equities analysts anticipate that The RMR Group will post 0.63 earnings per share for the current fiscal year. The RMR Group dividend announcement. The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 12th. Shareholders of record on Monday, October 19th will be paid a dividend of $0.45 per share. The ex-dividend date is Monday, October 19th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 10.2%. The RMR Group's dividend payout ratio (DPR) is presently 157.89%. Institutional inflows and outflows. Institutional investors have recently bought and sold shares of the stock. Bank of America Corp DE raised its position in shares of The RMR Group by 76.1% during the 1st quarter. Bank of America Corp DE now owns 941,252 shares of the financial services provider's stock worth $14,561,000 after purchasing an additional 406,888 shares during the last quarter. NewEdge Advisors LLC boosted its stake in The RMR Group by 139,802.2% during the 2nd quarter. NewEdge Advisors LLC now owns 64,355 shares of the financial services provider's stock worth $1,321,000 after purchasing an additional 64,309 shares during the last quarter. Globeflex Capital L P purchased a new stake in shares of The RMR Group during the second quarter worth $852,000. Principal Financial Group Inc. purchased a new stake in shares of The RMR Group during the first quarter worth $636,000. Finally, Aviance Capital Partners LLC raised its position in shares of The RMR Group by 41.7% in the first quarter. Aviance Capital Partners LLC now owns 90,134 shares of the financial services provider's stock valued at $1,394,000 after buying an additional 26,536 shares during the last quarter. 42.31% of the stock is currently owned by hedge funds and other institutional investors. The RMR Group company profile. The RMR Group Inc is an alternative asset management company that provides management services to publicly traded and private real estate companies. Its platform supports businesses that own and operate commercial real estate, including office, industrial, healthcare, senior living, hotel, and other property types. Discover more MarketBeat All Access Stock research tools Stock Market News RMR's services include property and asset management, leasing, acquisitions and dispositions, development and redevelopment, construction management, financing support, and strategic planning. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Before you consider The RMR Group, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The RMR Group wasn't on the list. While The RMR Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. The space race is growing fast, and you don't have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important. Continue following MarketBeat